Dragan Grabulovski

Dragan has been a co-founder and CSO of Covagen, a biotech company acquired by J&J in 2014. Since 2015 he’s been an advisor for leading venture capital companies, biotechnology firms and served as a startup coach for more than 15 projects in Switzerland and Germany within its mandates to ETH Zurich, TU Dresden and Innosuisse. He is currently a board member at Memo Therapeutics, Araris Biotech and a member of the strategic board at Biomunex.